Related references
Note: Only part of the references are listed.The MRN complex is transcriptionally regulated by MYCN during neural cell proliferation to control replication stress
M. Petroni et al.
CELL DEATH AND DIFFERENTIATION (2016)
New Use for an Old Reagent: Cell Cycle Analysis of DNA Content Using Flow Cytometry in Formamide Treated Cells
Maurizio Carbonari
CYTOMETRY PART A (2016)
Myc induced replicative stress response: How to cope with it and exploit it
Sara Rohban et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
Rad51-mediated replication fork reversal is a global response to genotoxic treatments in human cells
Ralph Zellweger et al.
JOURNAL OF CELL BIOLOGY (2015)
Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function
Felix Y. Feng et al.
MOLECULAR CELL (2015)
Identification and Pharmacological Inactivation of the MYCN Gene Network as a Therapeutic Strategy for Neuroblastic Tumor Cells
Olesya Chayka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
An update on PARP inhibitors-moving to the adjuvant setting
Amir Sonnenblick et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy
M. Li et al.
ONCOGENE (2015)
Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib
Junko Murai et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Preclinical Evaluation of the PARP Inhibitor, Olaparib, in Combination With Cytotoxic Chemotherapy in Pediatric Solid Tumors
Robin E. Norris et al.
PEDIATRIC BLOOD & CANCER (2014)
Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors
V. Veschi et al.
CELL DEATH & DISEASE (2014)
c-MYC-Induced Genomic Instability
Alexandra Kuzyk et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Rationale for Poly(ADP-ribose) Polymerase (PARP) Inhibitors in Combination Therapy with Camptothecins or Temozolomide Based on PARP Trapping versus Catalytic Inhibition
Junko Murai et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
The toxicity of nitrofuran compounds on melanoma and neuroblastoma cells is enhanced by Olaparib and ameliorated by melanin pigment
Ewan M. McNeil et al.
DNA REPAIR (2013)
Oncogenes induce genotoxic stress by mitotic processing of unusual replication intermediates
Kai J. Neelsen et al.
JOURNAL OF CELL BIOLOGY (2013)
The HMGA1 protoncogene frequently deregulated in cancer is a transcriptional target of E2F1
Isabella Massimi et al.
MOLECULAR CARCINOGENESIS (2013)
Human RECQ1 promotes restart of replication forks reversed by DNA topoisomerase I inhibition
Matteo Berti et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Cdc45 Is a Critical Effector of Myc-Dependent DNA Replication Stress
Seetha V. Srinivasan et al.
CELL REPORTS (2013)
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Junko Murai et al.
CANCER RESEARCH (2012)
Inhibition of Poly(ADP-Ribose) Polymerase Enhances the Toxicity of 131I-Metaiodobenzylguanidine/Topotecan Combination Therapy to Cells and Xenografts That Express the Noradrenaline Transporter
Anthony G. McCluskey et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Topoisomerase I poisoning results in PARP-mediated replication fork reversal
Arnab Ray Chaudhuri et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells
P. T. Ferrao et al.
ONCOGENE (2012)
Galectin-3 Impairment of MYCN-Dependent Apoptosis-Sensitive Phenotype Is Antagonized by Nutlin-3 in Neuroblastoma Cells
Veronica Veschi et al.
PLOS ONE (2012)
Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification
Linda J. Valentijn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
SMolecular mechanisms of MYCN-dependent apoptosis and the MDN2-p53 pathway: an Achillei's heel to be exploited for the therapy of MYCN-amplified neuroblastoma
Marialaura Petroni et al.
FRONTIERS IN ONCOLOGY (2012)
MYCN Sensitizes Human Neuroblastoma to Apoptosis by HIPK2 Activation through a DNA Damage Response
Marialaura Petroni et al.
MOLECULAR CANCER RESEARCH (2011)
The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings
Thomas Helleday
MOLECULAR ONCOLOGY (2011)
53BP1 nuclear bodies form around DNA lesions generated by mitotic transmission of chromosomes under replication stress
Claudia Lukas et al.
NATURE CELL BIOLOGY (2011)
Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors
Matilde Murga et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma
Kristina A. Cole et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Emergence of Micronuclei and Their Effects on the Fate of Cells under Replication Stress
Koh-ichi Utani et al.
PLOS ONE (2010)
Inhibition of Poly (ADP-Ribose) Polymerase-1 Enhances Temozolomide and Topotecan Activity against Childhood Neuroblastoma
Rachel A. Daniel et al.
CLINICAL CANCER RESEARCH (2009)
PARP is activated at stalled forks to mediate Mre11-dependent replication restart and recombination
Helen E. Bryant et al.
EMBO JOURNAL (2009)
Poor Survival for Infants With MYCN-Amplified Metastatic Neuroblastoma Despite Intensified Treatment: The International Society of Paediatric Oncology European Neuroblastoma Experience
Adela Canete et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Significance of MYCN Amplification in International Neuroblastoma Staging System Stage 1 and 2 Neuroblastoma: A Report From the International Neuroblastoma Risk Group Database
Rochelle Bagatell et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Susan L. Cohn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
Frank Westermann et al.
GENOME BIOLOGY (2008)
Non-transcriptional control of DNA replication by c-Myc
David Dominguez-Sola et al.
NATURE (2007)
Genomic instability during myc-induced lymphomagenesis in the bursa of fabricius
P. E. Neiman et al.
ONCOGENE (2006)
MYC can induce DNA breaks in vivo and in vitro independent of reactive oxygen species
Suma Ray et al.
CANCER RESEARCH (2006)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Share Paper
